This coverage index provides an overview of Kenya’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profile
Priorities for progress in Kenya
- Kenya should urgently address the supply chain issues that are heavily impacting the treatment of trachoma in the country.
- Further, it should work to build a strong preventive therapy programme with systematically high annual coverage across all of the five NTDs.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Treatment coverage increased from 60% in 2016 to 78% in 2017.
Treatment coverage decreased from 23% in 2016 to 12% in 2017.
Treatment coverage increased from 60% in 2016 to 66% in 2017.
Treatment coverage decreased from 42% in 2016 to 41% in 2017.
Kenya does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Kenya.